Science Explorer Back to mapMap

Most cited papers in Geriatrics and Gerontology

What are the most cited papers in Geriatrics and Gerontology?

The most cited paper in Geriatrics and Gerontology is "Frailty in Older Adults: Evidence for a Phenotype" (Linda P. Fried, Catherine M. Tangen, Jeremy D Walston et al., 2001), with 25,162 citations. Next come "The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (19,132) and "Prediction of Creatinine Clearance from Serum Creatinine" (15,456).

Showing 50 of 98 papers. Every paper with more than 2,086 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Frailty in Older Adults: Evidence for a Phenotype Linda P. Fried, Catherine M. Tangen, Jeremy D Walston et al. · The Journals of Gerontology Series A Mar 2001 25,162
2 The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al. · Alzheimer s & Dementia Open access 22 Apr 2011 19,132
3 Prediction of Creatinine Clearance from Serum Creatinine Donald W. Cockcroft, Henry Gault · ˜The œNephron journals/Nephron journals 28 Nov 2008 15,456
4 Sarcopenia: revised European consensus on definition and diagnosis Alfonso José Cruz-Jentoft et al. · Age and Ageing Open access 24 Sep 2018 14,151
5 A method for estimating the probability of adverse drug reactions C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics Aug 1981 11,879
6 Sarcopenia: European consensus on definition and diagnosis Alfonso José Cruz-Jentoft, Jean‐Pierre Baeyens, Jürgen Martin Bauer et al. · Age and Ageing Open access 13 Apr 2010 11,720
7 Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Christopher J L Murray et al. · The Lancet Open access940 authors Oct 2020 9,961
8 A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission Jack M. Guralnik, E. M. Simonsick, Luigi Ferrucci et al. · Journal of Gerontology Mar 1994 9,940
9 Frailty in elderly people Andrew Paul Clegg, John B. Young, Steve Iliffe et al. · The Lancet Open access 7 Feb 2013 9,683
10 A global clinical measure of fitness and frailty in elderly people Kenneth J. Rockwood · Canadian Medical Association Journal Open access 29 Aug 2005 9,214
11 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos et al. · The Lancet Open access358 authors Dec 2012 8,461
12 Adherence to Medication Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine 3 Aug 2005 8,018
13 Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment Liang‐Kung Chen et al. · Journal of the American Medical Directors Association Open access 4 Feb 2020 7,159
14 Dose translation from animal to human studies revisited Shannon Reagan‐Shaw, Minakshi Nihal, Nihal Ahmad · The FASEB Journal 17 Oct 2007 6,526
15 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 Christina Fitzmaurice et al. · JAMA Oncology Open access185 authors 5 Dec 2016 6,333
16 Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia Jeffrey Alan Lieberman, T. Scott Stroup, Joseph P. McEvoy et al. · New England Journal of Medicine Open access 19 Sep 2005 5,930
17 EuroQol: the current state of play Richard G. Brooks · Health Policy Jul 1996 5,926
18 Rehospitalizations among Patients in the Medicare Fee-for-Service Program Stephen F. Jencks, Mark V. Williams, Eric A. Coleman · New England Journal of Medicine Apr 2009 5,226
19 Incidence of Adverse Drug Reactions in Hospitalized Patients Jason Lazarou, Bruce H. Pomeranz, Paul Corey · JAMA 15 Apr 1998 4,842
20 Gait Speed and Survival in Older Adults Stephanie A. Studenski · JAMA Open access 4 Jan 2011 4,585
21 SF-36 Health Survey Update John E. Ware · Spine Dec 2000 4,515
22 Resveratrol improves health and survival of mice on a high-calorie diet Joseph A. Baur et al. · Nature Open access Nov 2006 4,279
23 Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia Liang‐Kung Chen et al. · Journal of the American Medical Directors Association 24 Jan 2014 4,202
24 Frailty Consensus: A Call to Action John Edward Morley, Bruno J. Vellas, Gabor Abellán van Kan et al. · Journal of the American Medical Directors Association Open access Jun 2013 4,166
25 Lower-Extremity Function in Persons over the Age of 70 Years as a Predictor of Subsequent Disability Jack M. Guralnik, Luigi Ferrucci, Eleanor Marie Simonsick et al. · New England Journal of Medicine Open access 2 Mar 1995 4,156
26 Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care Linda P. Fried, Luigi Ferrucci, Jonathan D. Darer et al. · The Journals of Gerontology Series A Open access Mar 2004 4,107
27 Epidemiology of Sarcopenia among the Elderly in New Mexico Richard Baumgartner, Kathleen M. Koehler, Dympna Gallagher et al. · American Journal of Epidemiology 15 Apr 1998 4,054
28 Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α Marie Lagouge, Carmen Argmann, Zachary Gerhart‐Hines et al. · Cell Open access 17 Nov 2006 4,041
29 SOME QUANTITATIVE USES OF DRUG ANTAGONISTS O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy Open access Mar 1959 3,967
30 Therapeutic potential of resveratrol: the in vivo evidence Joseph A. Baur, David A. Sinclair · Nature Reviews Drug Discovery Review 26 May 2006 3,951
31 Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Konrad T. Howitz, Kevin J. Bitterman, Haim Yosef Cohen et al. · Nature 24 Aug 2003 3,797
32 Development and psychometric evaluation of the Resilience Scale. Gail M. Wagnild, Heather M. Young · PubMed 1993 3,774
33 Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty Luigi Ferrucci, Elisa Fabbri · Nature Reviews Cardiology ReviewOpen access 31 Jul 2018 3,731
34 A standard procedure for creating a frailty index Samuel D. Searle, Arnold Mitnitski, Evelyne A. Gahbauer et al. · BMC Geriatrics Open access 30 Sep 2008 3,684
35 Self-eating and self-killing: crosstalk between autophagy and apoptosis Maria Chiara Maiuri, Einat Zalckvar, Adi Kimchi et al. · Nature Reviews Molecular Cell Biology Review 23 Aug 2007 3,659
36 Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission Gill Livingston et al. · The Lancet Open access 31 Jul 2024 3,635
37 Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Shin‐ichiro Imai, Christopher M. Armstrong, Matt R. Kaeberlein et al. · Nature Feb 2000 3,531
38 The APACHE III Prognostic System William A. Knaus, Douglas P. Wagner, Elizabeth A. Draper et al. · CHEST Journal Dec 1991 3,502
39 COSMIN guideline for systematic reviews of patient-reported outcome measures C.A.C. Prinsen, Lidwine Brigitta Mokkink, L.M. Bouter et al. · Quality of Life Research ReviewOpen access 12 Feb 2018 3,453
40 Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Catherine Owens Johnson et al. · The Lancet Neurology Open access273 authors 11 Mar 2019 3,411
41 What is polypharmacy? A systematic review of definitions Nashwa Masnoon, Sepehr Shakib, Lisa M. Kalisch Ellett et al. · BMC Geriatrics ReviewOpen access 10 Oct 2017 3,401
42 Frailty: implications for clinical practice and public health Emiel O. Hoogendijk, Jonathan Afilalo, Kristine E. Ensrud et al. · The Lancet Oct 2019 3,395
43 The World report on ageing and health: a policy framework for healthy ageing John Beard, Alana Officer, Islène Araujo de Carvalho et al. · The Lancet Open access 3 Nov 2015 3,333
44 Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia Roger A. Fielding et al. · Journal of the American Medical Directors Association Open access 5 Mar 2011 3,319
45 AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Carles Cantó, Zachary Gerhart‐Hines, Jérôme N. Feige et al. · Nature Open access 4 Mar 2009 3,299
46 Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase Anne Sophie Brunet, Lora B. Sweeney, James Fitzhugh Sturgill et al. · Science 23 Feb 2004 3,267
47 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ Open access Jul 2004 3,262
48 Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells Ying Yang, Shuping Li, Qiao Yang et al. · Cellular Physiology and Biochemistry Open access 2014 3,256
49 American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel · Journal of the American Geriatrics Society 29 Jan 2019 3,220
50 Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability Ian Janssen, Steven B. Heymsfield, Robert R. Ross · Journal of the American Geriatrics Society May 2002 3,175

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.